Evidence map›Paper›PMID 38179550›Full record

ArticleCase reports in oncology

Primary Peritoneal Carcinosarcoma in a Breast Cancer Patient Harboring a Germline

Luciana Beatriz Mendes Gomes, Renata Lazari Sandoval, Camila Bragança Xavier, Tatiana Strava Correa, Raquel Midori Koga Matuda, Zenaide Silva de Souza, Luiz Guilherme Cernaglia Aureliano de Lima, Mariana Petaccia de Macedo, Filomena Marino Carvalho, Daniele Assad Suzuki

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Case reports in oncology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Luciana Beatriz Mendes GomesOncology Center, Hospital Sirio-Libanes, Brasilia, Brazil.
Renata Lazari SandovalOncology Center, Hospital Sirio-Libanes, Brasilia, Brazil.
Camila Bragança XavierOncology Center, Hospital Sirio-Libanes, São Paulo, Brazil.
Tatiana Strava CorreaOncology Center, Hospital Sirio-Libanes, Brasilia, Brazil.
Raquel Midori Koga MatudaOncology Center, Hospital Sirio-Libanes, Brasilia, Brazil.
Zenaide Silva de SouzaOncology Center, Hospital Sirio-Libanes, Brasilia, Brazil.
Luiz Guilherme Cernaglia Aureliano de LimaDepartment of Pathology, Hospital Sirio-Libanes, São Paulo, Brazil.
Mariana Petaccia de MacedoDepartment of Pathology, Hospital Sirio-Libanes, São Paulo, Brazil.
Filomena Marino CarvalhoDepartment of Pathology, Faculdade de Medicina FMUSP, Universidade de São Paulo, São Paulo, Brazil.
Daniele Assad SuzukiOncology Center, Hospital Sirio-Libanes, Brasilia, Brazil.
Hospital Sírio-Libanês · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Malignant mixed müllerian tumor (MMMT) is a rare neoplasm, consisting of carcinomatous (epithelial) and sarcomatous (mesenchymal) components that most commonly arise in the endometrium and more infrequently in the ovaries, fallopian tube, cervix, and vagina. Primary peritoneal carcinosarcoma (PPCS) is an extremely rare extragenital presentation of MMMT. Although the occurrence of breast cancer and epithelial ovarian carcinoma in association with

Indexed as

Case reportGermline BRCA2 pathogenic variantPrimary peritoneal carcinosarcoma

Identifiers

PMID38179550
PMCPMC10764087
OpenAlexW4390532493

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.